大涨638%!LogicBio(LOGC.US)与阿斯利康子公司达成收购协议

智通财经2022-10-04

智通财经APP获悉,10月3日,阿斯利康罕见病业务子公司Alexion宣布,已与Lexington公司(LOGC.US)达成最终收购协议。此次收购计划旨在通过LogicBio的独特技术、经验丰富的罕见病研发团队以及临床前开发方面的专业知识,快速加速Alexion在基因组药物领域的增长。受此消息影响,周一Lexington(LOGC.US)股价大涨637.61%。根据协议条款,Alexion将通过...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1